David Sallman | ASH 2018 | Key results of the phase I THINK trial of NKG2D CAR-T therapy in R/R AML
For scientific research only, not for patients.
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
SMILES Code:
InChi Code:
InChi Key:
Keyword:
Solubility:
Storage:
Description:
Target: